CA2222790A1 - Derives de la quinoleine contenant un diol comme antagonistes des leucotrienes - Google Patents

Derives de la quinoleine contenant un diol comme antagonistes des leucotrienes Download PDF

Info

Publication number
CA2222790A1
CA2222790A1 CA002222790A CA2222790A CA2222790A1 CA 2222790 A1 CA2222790 A1 CA 2222790A1 CA 002222790 A CA002222790 A CA 002222790A CA 2222790 A CA2222790 A CA 2222790A CA 2222790 A1 CA2222790 A1 CA 2222790A1
Authority
CA
Canada
Prior art keywords
acid
compound
formula
phenyl
propandiol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002222790A
Other languages
English (en)
Inventor
Schneur Rachlin
Dorte Kirstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002222790A priority Critical patent/CA2222790A1/fr
Publication of CA2222790A1 publication Critical patent/CA2222790A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés inconnus jusqu'à présent, ayant la formule (I). Dans cette formule, R¿1? est un hydrogène ou un halogène, de préférence le fluor ou le chlore et m correspond à 0, 1 ou 2. Ces composés sont utiles en médecine humaine et vétérinaire comme antagonistes des leucotriènes.
CA002222790A 1995-11-27 1996-11-13 Derives de la quinoleine contenant un diol comme antagonistes des leucotrienes Abandoned CA2222790A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002222790A CA2222790A1 (fr) 1995-11-27 1996-11-13 Derives de la quinoleine contenant un diol comme antagonistes des leucotrienes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9524185.7 1995-11-27
CA002222790A CA2222790A1 (fr) 1995-11-27 1996-11-13 Derives de la quinoleine contenant un diol comme antagonistes des leucotrienes

Publications (1)

Publication Number Publication Date
CA2222790A1 true CA2222790A1 (fr) 1997-06-05

Family

ID=4161814

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002222790A Abandoned CA2222790A1 (fr) 1995-11-27 1996-11-13 Derives de la quinoleine contenant un diol comme antagonistes des leucotrienes

Country Status (1)

Country Link
CA (1) CA2222790A1 (fr)

Similar Documents

Publication Publication Date Title
JP2608788B2 (ja) 精神分裂病治療剤
EP0420844B1 (fr) Quinoleines substituees
US4826987A (en) Pyridyl and quinoline derivatives
WO1991009029A1 (fr) Benzimidazoles chloro-substitues therapeutiquement actifs, leurs procedes de preparation et leur utilisation
JP6692354B2 (ja) １，４−ジ置換イミダゾール誘導体
CN100379742C (zh) 用作ltd4拮抗剂的新型三环衍生物
EP0863876B1 (fr) Derives de la quinoleine contenant un diol comme antagonistes des leucotrienes
WO1997019925A9 (fr) Derives de la quinoleine contenant un diol comme antagonistes des leucotrienes
CA2222790A1 (fr) Derives de la quinoleine contenant un diol comme antagonistes des leucotrienes
US5576438A (en) Isoserine derivatives and their use as leukotriene antagonists
IE911913A1 (en) Benzoic acid derivatives for treating leukotriene-related¹diseases
JPH107571A (ja) 肺癌治療におけるナフタレン誘導体の使用
US5234932A (en) Substituted quinolines and leucotriene antagonism treatment therewith
JP2002528541A (ja) Ｔｎｆおよびｐｄｅ−ｉｖ阻害活性を有する複素環式化合物のｎ−オキシド
US20030097000A1 (en) 2-Phenyl-quinoline derivatives, preparation method and therapeutic use thereof
EP0773931A1 (fr) Derives de quinoleine antagonistes des leucotrienes
WO1992016104A1 (fr) Antagonistes des leucotrienes
JP2010505803A (ja) リムカゾールの製造
JPH09505605A (ja) 置換ピリジンロイコトリエンｂ▲下４▼拮抗物質
JPS6320430B2 (fr)

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued